Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
BMC Musculoskelet Disord ; 14: 184, 2013 Jun 12.
Artículo en Inglés | MEDLINE | ID: mdl-23758943

RESUMEN

BACKGROUND: Back pain is a major public health problem due to its high frequency, to the resulting activity constraint, and the need for surgery in many cases. Back pain is more frequent in women than men, mainly in postmenopausal women. High prevalence of hypovitaminosis D has been detected in postmenopausal women, and it is associated with decreased bone mass, sarcopenia, vertebral fractures, and inflammation, which can be related to back pain. METHODS: The relation between back pain and hypovitaminosis D was evaluated in this study, as well the difference regarding the number of bedridden days, number of days away from work, and daily activities limitation between women with and without hypovitaminosis D. This study reviewed baseline data from an interventional phase III multicenter trial in low bone mass postmenopausal women. The study included demographic data, 25OHD determinations, Newitt/Cummings questionnaire on back pain, and vertebral fracture identified thought X-ray evaluation. RESULTS: The trial included 9354 participants, but only 9305 underwent all the evaluations. The age median was 67 (60 - 85 years old) and age at menopause was 49 (18 - 72 years). Hypovitaminosis D was found in 22.5% of the subjects, 15.3% of them had vertebral fractures, 67.5% with back pain, and 14.8% reduced their daily activities in the previous six months. Subjects with hypovitaminosis D, compared to those without hypovitaminosis D, reported more back pain (69.5 v 66.9%, p: 0.022), more cases of severe back pain (8.5% v 6.8%, p: 0,004), higher limitation in their daily activities (17.2 v 14.0%, p: 0.001), and more fractures (17.4 v 14.6%, p: 0,002); also, they had more trouble to perform daily activities addressed in the Newwit/Cummings questionnaire. CONCLUSION: Hypovitaminosis D was related to back pain, to its severity, and to difficulty in perform daily activities. TRIAL REGISTRATION: ClinicalTrial.gov: NCT00088010.


Asunto(s)
Dolor de Espalda/sangre , Dolor de Espalda/diagnóstico , Densidad Ósea/fisiología , Posmenopausia/sangre , Deficiencia de Vitamina D/sangre , Deficiencia de Vitamina D/diagnóstico , Actividades Cotidianas , Anciano , Anciano de 80 o más Años , Dolor de Espalda/epidemiología , Estudios Transversales , Femenino , Humanos , Persona de Mediana Edad , Deficiencia de Vitamina D/epidemiología
2.
Arq Bras Endocrinol Metabol ; 50(4): 793-801, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17117304

RESUMEN

Glucocorticoid-induced osteoporosis is the most frequent cause of secondary osteoporosis. Glucocorticoids cause a rapid bone loss in the first few months of use, but the most important effect of the drug is suppression of bone formation. The administration of oral glucocorticoid is associated with an increased risk of fractures at the spine and hip. The risk is related to the dose, but even small doses can increase the risk. Patients on glucocorticoid therapy lose more trabecular than cortical bone and the fractures are more frequent at the spine than at the hip. Calcium, vitamin D and activated forms of vitamin D can prevent bone loss and antiresorptive agents are effective for prevention and treatment of bone loss and to decrease fracture risk. Despite the known effects of glucocorticoids on bone, only a few patients are advised to take preventive measures and treat glucocorticoid-induced osteoporosis.


Asunto(s)
Glucocorticoides/efectos adversos , Osteoporosis/inducido químicamente , Biomarcadores , Densidad Ósea , Resorción Ósea/prevención & control , Huesos , Fracturas de Cadera/prevención & control , Humanos , Osteoporosis/diagnóstico , Osteoporosis/prevención & control , Guías de Práctica Clínica como Asunto , Fracturas de la Columna Vertebral/prevención & control
3.
Cien Saude Colet ; 13(3): 1023-32, 2008.
Artículo en Portugués | MEDLINE | ID: mdl-18813596

RESUMEN

This paper assesses the quality of assistance in a clinical trial outpatient center as well as the patients understanding of the informed consent (IC); determine the reasons why they participate and detail socio-economic levels. A cross-sectional study was adopted in a clinical trial outpatient center using a self-explanatory questionnaire. All 100 respondents considered the assistance at the center excellent (86%) or good (9%). Almost all of them were well informed about the content of the IC. Their knowledge about the right to "confidentiality", present in all ICs, was 6 times higher than their knowledge about their right to "access the results", generally not included in the IC. The main reasons for participating were "to know more about ones health" (59%) and to "to benefit other people in the future" (47%). The participants income varied from 3 to 5 minimum wages (48%) and most (66%) concluded at least the 4th grade of basic education in Brazil. The subjects showed the economical characteristics of the average population of Rio de Janeiro. Their level of education allowed them to sign and to understand what they were signing. They were aware of the existence of the IC and its content. The main reason for participating was for one s own benefit and for the benefit of others.


Asunto(s)
Instituciones de Atención Ambulatoria/normas , Ensayos Clínicos como Asunto/normas , Consentimiento Informado , Satisfacción del Paciente , Estudios Transversales , Humanos , Encuestas y Cuestionarios
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda